14
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6002 | Enzalutamide | MDV3100 | Androgen Receptor , Autophagy |
Enzalutamide (MDV3100) is an androgen receptor (AR) antagonist (IC50=36 nM in LNCaP). Enzalutamide activates autophagy, has antitumor activity, and is commonly used in the treatment of desmoplasia-resistant prostate canc... | |||
T8217 | Enzalutamide carboxylic acid | Androgen Receptor , Drug Metabolite | |
Enzalutamide carboxylic acid is an antagonist of androgen receptor (AR) . | |||
T19450 | N-desmethyl Enzalutamide | N-desmethyl MDV 3100 | Androgen Receptor |
N-desmethyl Enzalutamide (N-desmethyl MDV 3100) is the active Enzalutamide metabolite.It is the active metabolite of Enzalutamide. N-desmethyl Enzalutamide demonstrates primary and secondary pharmacodynamics of similar p... | |||
T11208 | Enzalutamide-d3 | MDV3100 D3 | Others |
Enzalutamide D3 is a deuterium labeled Enzalutamide . Enzalutamide is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells. | |||
T19449 | N-desmethyl Enzalutamide D6 | N-desmethyl MDV 3100 D6 | Androgen Receptor |
N-desmethyl Enzalutamide D6 is a deuterium labeled N-desmethyl Enzalutamide. | |||
T19311 | Enzalutamide carboxylic acid D6 | MDV3100 carboxylic acid D6 | Others |
Enzalutamide carboxylic acid is an inactive metabolite of Enzalutamide. Enzalutamide carboxylic acid D6 is the deuterium labeled Enzalutamide carboxylic acid (MDV3100 carboxylic acid). | |||
T13273 | UT-34 | Androgen Receptor | |
UT-34 is a selective and orally active antagonist of second-generation pan-androgen receptor (AR) and degrader(IC50s of 211.7 nM, 262.4 nM and 215.7 nM for wild-type, F876L and W741L AR, respectively), and has anti-prost... | |||
T69564 | YK-2-69 | ||
YK-2-69 is a highly selective DYRK2 inhibitor which specifically interacts with Lys-231 and Lys-234 in the co-crystal structure. Especially, YK-2-69 exhibits more potent anti-PCa efficacy than the first-line drug enzalut... | |||
T29214 | ZEN-3694 | ZEN 3694,ZEN3694 | Epigenetic Reader Domain |
ZEN-3694 (ZEN 3694) is a bromo-structural domain extra-terminal inhibitor (BETi) with activity in androgen signaling inhibitor (ASI) resistance models and can be used in combination with enzalutamide to study metastatic ... | |||
T29110 | VPC-13163 | 2,3-dihydro-2,3'-Bi-1H-indole,VPC13163,NSC52361,NSC 52361,VPC 13163 | Others |
VPC-13163 (NSC-52361) has strong anti-proliferative activity against LNCaP and Enzalutamide-resistant prostate cancer cell lines (MR49F) whereas it did not affect the growth of AR independent PC3 cell line. It also inhib... | |||
T39954 | AU-15330 | Epigenetic Reader Domain , PROTACs | |
AU-15330 is a protein hydrolysis-targeted chimeric (PROTAC) degrader of the SWI/SNF ATPase subunits SMARCA2 and SMARCA4.AU-15330 potently inhibits tumor growth in a prostate cancer xenograft model and acts synergisticall... | |||
T14318 | ARCC-4 | Others | |
ARCC-4 is an enzalutamide-based von Hippel-Lindau (VHL)-recruiting AR PROTAC and outperforms enzalutamide and it is a low-nanomolar androgen receptor (AR) degrader based on PROTAC, with a DC50 of 5 nM. ARCC-4 effectively... | |||
T63811 | EPI-7170 | ||
EPI-7170 is a ralaniten analogue and a potent antagonist of the androgen receptor N-terminal structural domain, blocking the transcriptional activity of the full-length AR (FL-AR) and AR splice variants (AR-Vs). EPI-7170... | |||
T79519 | YXG-158 | Androgen Receptor | |
YXG-158 (Compound 23-h), an orally active androgen receptor (AR) degrader and cytochrome P450 17A1 (CYP17A1) inhibitor, exhibits AR degradation with a DC50 of 1.28 μM and CYP17A1 inhibition with an IC50 of 100 nM. It is ... |